Standout Papers

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer 2020 2026 2022 2024343
  1. Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer (2020)
    Vicky Makker, Matthew H. Taylor et al. Journal of Clinical Oncology

Immediate Impact

4 by Nobel laureates 2 from Science/Nature 64 standout
Sub-graph 1 of 23

Citing Papers

Tumour vasculature at single-cell resolution
2024 StandoutNature
Polymeric Nanoparticles for Drug Delivery
2024 Standout
4 intermediate papers

Works of Mark Messing being referenced

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
2020 Standout
Phase II Evaluation of Nanoparticle Albumin–Bound Paclitaxel in Platinum-Sensitive Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
2009

Author Peers

Author Last Decade Papers Cites
Mark Messing 460 218 293 412 29 1.0k
W. Michael Hogan 512 301 359 376 33 1.3k
Darren Wheeler 554 281 389 253 30 1.1k
Emanuela Veras 543 148 346 226 24 1.1k
Abbie L. Fields 451 321 480 312 42 1.2k
Creasman Wt 358 188 293 297 19 914
Michele De Nictolis 474 215 340 320 52 1.3k
Pentti Lehtovirta 472 139 431 230 43 1.1k
Hironori Tashiro 452 190 247 351 37 1.3k
Germana Tognon 724 179 584 320 36 1.2k
Neil J. Finkler 477 271 461 246 33 1.2k

All Works

Loading papers...

Rankless by CCL
2026